Universal-Beteiligungs- und Servicegesellschaft’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.39M Sell
99,852
-4,802
-5% -$249K 0.01% 837
2026
Q1
$5.04M Buy
104,654
+45,962
+78% +$2.04M 0.01% 866
2025
Q4
$2.42M Sell
58,692
-1,652
-3% -$66.3K ﹤0.01% 1199
2025
Q3
$2.34M Buy
60,344
+51,204
+560% +$1.66M ﹤0.01% 1224
2025
Q2
$253K Buy
+9,140
New +$233K ﹤0.01% 1873

Other funds holding KNSA

Universal-Beteiligungs- und Servicegesellschaft's KNSA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Kiniksa Pharmaceuticals (KNSA) stake by 4.6% in Q2 2026, selling an estimated $249K and leaving 99,852 shares worth $6.39M. The position accounts for 0.01% of the portfolio, ranked #837.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in KNSA in Q2 2025 and has held it in 5 quarters since. 191 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 99,852 shares of Kiniksa Pharmaceuticals worth $6.39M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 4,802 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $249K.
  • Kiniksa Pharmaceuticals made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #837 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 191 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.